Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term doxofylline monotherapy study in adults with asthma
ISRCTN10030693Phase 3Completed
- Sponsor
- Roberts Pharmaceutical
- Start
- Feb 1992
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxofylline in asthma, sponsored by Roberts Pharmaceutical. Primary endpoint: FEV1 at month 12. Started Feb 1992; status: completed.
02
Drugs
doxofylline
03
Conditions
asthma
Beyond the preview
Go deeper on ISRCTN10030693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10030693.